Logo image of BFK

BLACKROCK MUNICIPAL INC TRST (BFK) Stock Fundamental Analysis

NYSE:BFK - New York Stock Exchange, Inc. - US09248F1093 - Currency: USD

10.345  +0.09 (+0.83%)

Fundamental Rating

1

Taking everything into account, BFK scores 1 out of 10 in our fundamental rating. BFK was compared to 0 industry peers in the Unkown industry. BFK has a bad profitability rating. Also its financial health evaluation is rather negative. BFK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BFK has reported negative net income.
In multiple years BFK reported negative net income over the last 5 years.
In the past 5 years BFK always reported a positive cash flow from operatings.
BFK Yearly Net Income VS EBIT VS OCF VS FCFBFK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA -0.67%
ROE -1.04%
ROIC 2.33%
ROA(3y)0.32%
ROA(5y)0.42%
ROE(3y)0.18%
ROE(5y)0.43%
ROIC(3y)3.03%
ROIC(5y)3.24%
BFK Yearly ROA, ROE, ROICBFK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

In the last couple of years the Operating Margin of BFK has declined.
In the last couple of years the Gross Margin of BFK has declined.
Industry RankSector Rank
OM 51.03%
PM (TTM) N/A
GM 52.01%
OM growth 3Y-8.68%
OM growth 5Y-5.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.49%
GM growth 5Y-5.76%
BFK Yearly Profit, Operating, Gross MarginsBFK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

2

2. Health

2.1 Basic Checks

BFK has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BFK has been reduced compared to 5 years ago.
Compared to 1 year ago, BFK has an improved debt to assets ratio.
BFK Yearly Shares OutstandingBFK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BFK Yearly Total Debt VS Total AssetsBFK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

BFK has an Altman-Z score of 0.76. This is a bad value and indicates that BFK is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.21 indicates that BFK is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 0.76
ROIC/WACCN/A
WACCN/A
BFK Yearly LT Debt VS Equity VS FCFBFK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.16 indicates that BFK may have some problems paying its short term obligations.
A Quick Ratio of 0.16 indicates that BFK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
BFK Yearly Current Assets VS Current LiabilitesBFK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.65% over the past year.
Looking at the last year, BFK shows a decrease in Revenue. The Revenue has decreased by -6.43% in the last year.
Measured over the past years, BFK shows a decrease in Revenue. The Revenue has been decreasing by -5.53% on average per year.
EPS 1Y (TTM)93.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.83%
Revenue 1Y (TTM)-6.43%
Revenue growth 3Y-7.54%
Revenue growth 5Y-5.53%
Sales Q2Q%0.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BFK Yearly Revenue VS EstimatesBFK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BFK Yearly EPS VS EstimatesBFK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BFK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFK Price Earnings VS Forward Price EarningsBFK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFK Per share dataBFK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.37%, BFK is a good candidate for dividend investing.
BFK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 5.37%

5.2 History

The dividend of BFK decreases each year by -9.15%.
BFK has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BFK decreased recently.
Dividend Growth(5Y)-9.15%
Div Incr Years1
Div Non Decr Years1
BFK Yearly Dividends per shareBFK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BFK has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-192.02%
EPS Next 2YN/A
EPS Next 3YN/A
BFK Yearly Income VS Free CF VS DividendBFK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

More info and screens

BLACKROCK MUNICIPAL INC TRST

NYSE:BFK (2/5/2025, 10:26:21 AM)

10.345

+0.09 (+0.83%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)10-03 2024-10-03
Earnings (Next)04-01 2025-04-01
Inst Owners39.55%
Inst Owner Change4.08%
Ins OwnersN/A
Ins Owner Change0.53%
Market Cap453.63M
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 5.37%
Yearly Dividend0.48
Dividend Growth(5Y)-9.15%
DP-192.02%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-15 2025-01-15 (0.05)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.77
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.81
BVpS11.56
TBVpS11.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.67%
ROE -1.04%
ROCE 2.95%
ROIC 2.33%
ROICexc 2.36%
ROICexgc 2.36%
OM 51.03%
PM (TTM) N/A
GM 52.01%
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.42%
ROE(3y)0.18%
ROE(5y)0.43%
ROIC(3y)3.03%
ROIC(5y)3.24%
ROICexc(3y)3.03%
ROICexc(5y)3.24%
ROICexgc(3y)3.03%
ROICexgc(5y)3.24%
ROCE(3y)3.83%
ROCE(5y)4.1%
ROICexcg growth 3Y-6.02%
ROICexcg growth 5Y-3.46%
ROICexc growth 3Y-6.02%
ROICexc growth 5Y-3.46%
OM growth 3Y-8.68%
OM growth 5Y-5.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.49%
GM growth 5Y-5.76%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 0.76
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.43%
Revenue growth 3Y-7.54%
Revenue growth 5Y-5.53%
Sales Q2Q%0.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.18%
EBIT growth 3Y-15.56%
EBIT growth 5Y-11.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.41%
FCF growth 3Y110.19%
FCF growth 5Y28.27%
OCF growth 1Y135.41%
OCF growth 3Y110.19%
OCF growth 5Y28.27%